HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Aftercare (After-Treatment)

The care and treatment of a convalescent patient, especially that of a patient after surgery.

Also Known As:

After-Treatment; After Care; Postabortal Programs; Postabortion; After Treatment; After-Treatments; Postabortal Program; Program, Postabortal; Programs, Postabortal

Networked: 31615 relevant articles (2392 outcomes, 2345 trials/studies) for this Therapy, Comments

Relationship Network

Therapy Context: Research Results

Experts

1.	Fosså, Sophie D: 11 articles (10/2012 - 09/2003)
2.	Verdonck-de Leeuw, Irma M: 9 articles (06/2012 - 11/2004)
3.	Langendijk, Johannes A: 9 articles (06/2012 - 11/2004)
4.	Morris, Christopher G: 8 articles (12/2012 - 12/2003)
5.	Zhang, Jing: 8 articles (05/2012 - 12/2004)
6.	Carroll, Peter R: 8 articles (09/2011 - 06/2003)
7.	Wang, Wei: 8 articles (06/2011 - 10/2002)
8.	Wang, Lei: 8 articles (11/2008 - 02/2005)
9.	Chen, Y: 7 articles (08/2012 - 04/2000)
10.	Zhang, Hong: 7 articles (01/2012 - 01/2002)

Related Diseases

1.	Neoplasms (Cancer) 07/01/2006 - "Pregnancy rates and pregnancy outcomes particularly regarding in term delivery is the best after treatment of early stages of cervical cancer using proposed protocol, while very promising results are published in studies with radical vaginal trachelectomy as well. " 11/15/2006 - "When treatment was given 4 weeks after cell inoculation, the TFFs were 25%, 22%, 50%, and 61% after treatment with 25, 50, 100, or 200 kBq (211)At-MX35 F(ab')2, respectively, the specific energy to irradiated cell nuclei varying between approximately 2 and approximately 400 Gy. As a significant increase in the therapeutic efficacy was observed between the activity levels of 50 and 100 kBq (TFF increase from 22% to 50%), the conclusion was that the MRA is approximately 100 kBq (211)At-MX35 F(ab')2. MCP was most consistent with the TFF when assuming a diffusion depth of 30 mum of the mAbs in the tumors." 09/01/2005 - "No significant differences were found for subsites after treatment, although patients with mobile tongue tumors showed the best results. " 06/01/2005 - "Most recurrences occurred after a long disease-free interval after treatment and often outside the initial tumor site. " 01/01/2003 - "The best candidate for surgery had no evidence of additional metastatic disease, good performance status, and a long disease-free interval after treatment of the primary tumor. " Order ALL the reference details at left...
2.	Pain (Aches) 06/01/2010 - "Half of patients have complete pain relief five years after treatment, with best results obtained if treatment is performed early after the first pain attack. " 01/01/2010 - "Seven hundred and eighty-eight patients with clinically confirmed FM and baseline pain > or =40 mm on a 100 mm visual analogue scale ranked 5 FM clinical features that the subjects would most like to see improved after treatment (one for each priority quintile) from a list of 20 developed during focus groups. " 09/01/2009 - "All had highly significant improvement in their recorded pain profile scores measured at 3 months after treatment (p<0.001). " 04/01/2007 - "Results from the highly disabled patients showed statistically significant change after treatment in eight of nine outcome variables, including improvements in pain-related distress, disability, depression, pain-related anxiety, daytime rest, and performance during an activity tolerance test. " 08/01/2004 - "Soon after treatment, symptoms disappeared or improved in most children irrespective of eradication, but epigastric pain recurred in the majority of the still-infected children within 2 years." Order ALL the reference details at left...
3.	Infection 08/01/1999 - "Patients' desire to know whether their infection has been cured and symptom status after treatment are two important determinants of whether confirmatory H. " 02/01/1992 - "One patient died because of infection, whereas the other two persisted in complete remission after treatment at 4 and 5 years of follow-up, respectively. " 01/01/1981 - "The complete clearance of both infections (i.e., no eggs whether dead or alive) 6 months after treatment was 29% (43 patients). " 02/01/2012 - "No statistically significant differences were observed with spontaneous resolution of infection or with viral clearance after treatment. " 07/30/2008 - "brasiliensis infection significantly increased the degree of inhibition of AChE in the brain and diaphragm after treatment with CPO and PO in association with a significant reduction in PON1 activity. " Order ALL the reference details at left...
4.	Neoplasm Metastasis (Metastasis) 01/14/2010 - "24 patients were in complete remission after treatment (12 of these had all the metastases surgically removed before treatment). " 05/01/2009 - "In naive mice, reovirus delivered either neat or through cell carriage was detectable in the tumour-draining lymph nodes 3 days after treatment, though complete clearance of metastases was only obtained when the virus was delivered on T cells or mature DC (mDC); neat reovirus or loaded immature DC (iDC) gave only partial early tumour clearance. " 01/01/2005 - "The patient was successfully treated by surgical excision of the metastasis and adjuvant whole brain radiation therapy, and she was disease-free at the 6-month follow-up after treatment of the recurrence." 02/01/2004 - "Patients with LR relapse and distant metastasis had a high rate of remission after treatment. " 01/01/2002 - "Significant reduction was observed after treatment which became elevated again when there was recurrence or metastasis. " Order ALL the reference details at left...
5.	Body Weight (Weight, Body) 11/01/2011 - "There was a significant reduction in body weight, organs and increased body temperature, locomotor activity after treatment with extracts. " 05/01/2008 - "After treatment, degree of breast engorge, lactating volume, neonate body weight, artificial feeding frequency and volume, urination frequency and crying time of neonate were significantly improved in the two groups, with no significant difference between the two groups. " 01/01/2007 - "UC activity index was lower and body weight was higher in the two CE groups than those in the model group respectively, showing significant difference (P < 0.05 or P < 0.01); pathological examination showed the pathological changes and inflammatory response in colonic tissue were relieved significantly after treatment, and the improvement in the CE-H group was better than that in the SASP group. " 01/01/2005 - "A significant reduction in the body weight after treatment reflected by a significant reduction in the BMI was noted. " 11/15/2004 - "Intraperitoneal injection of LPS (100 microg kg(-1)) induced a significant reduction in food intake and body weight, which were significantly reversed in the presence of LAS (1 ml kg(-1)), 8 and 24 h after treatment. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Prednisolone (Predate)
2.	Adrenal Cortex Hormones (Corticosteroids)
3.	Cyclophosphamide (Cytoxan)
4.	rituximab (Mabthera)
5.	Interferon-alpha (Interferon Alfa)
6.	Immunoglobulins (Immunoglobulin)
7.	Budesonide (Pulmicort)
8.	Glucose (Dextrose)
9.	Anti-Bacterial Agents (Antibiotics)
10.	Ivermectin (Mectizan)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Radiotherapy
3.	Injections
4.	Heterologous Transplantation (Xenotransplantation)
5.	Combination Drug Therapy (Combination Chemotherapy)

blog comments powered by Disqus

TREATMENT OPTIONS
for Neoplasms,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 25767 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$24.95 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$490.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>